Journal article

Biological therapy after COVID-19 infection No reactivation of a COVID-19 infection with positive SARS-CoV-2 antibody status under biological therapy


Authors list: Steinchen, N.; Mueller-Ladner, U.; Lange, U.

Publication year: 2020

Pages: 574-577

Journal: Zeitschrift für Rheumatologie

Volume number: 79

Issue number: 6

ISSN: 0340-1855

eISSN: 1435-1250

Open access status: Hybrid

DOI Link: https://doi.org/10.1007/s00393-020-00824-0

Publisher: Springer


Abstract: 
A case with rheumatoid arthritis and insufficient compensation under disease-modifying combined long-term therapy with methotrexate and leflunomide is reported. After recovery from a COVID-19 infection, a tumor necrosis factor (TNF) inhibitor therapy was initiated. Until now no reactivation of the COVID-19 infection with positive SARS-CoV-2 antibody status has occurred.



Citation Styles

Harvard Citation style: Steinchen, N., Mueller-Ladner, U. and Lange, U. (2020) Biological therapy after COVID-19 infection No reactivation of a COVID-19 infection with positive SARS-CoV-2 antibody status under biological therapy, Zeitschrift für Rheumatologie, 79(6), pp. 574-577. https://doi.org/10.1007/s00393-020-00824-0

APA Citation style: Steinchen, N., Mueller-Ladner, U., & Lange, U. (2020). Biological therapy after COVID-19 infection No reactivation of a COVID-19 infection with positive SARS-CoV-2 antibody status under biological therapy. Zeitschrift für Rheumatologie. 79(6), 574-577. https://doi.org/10.1007/s00393-020-00824-0



Keywords

BIOLOGICAL THERAPY; COVID-19 infection; EULAR RECOMMENDATIONS; Immunsuppression; Positive antibody status SARS-CoV2; RHEUMATOID-ARTHRITIS

Last updated on 2025-10-06 at 11:12